Estribor, Maricyl .
HRN: 01-31-71 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/19/2023
CEFAZOLIN 1GM (VIAL)
08/19/2023
08/26/2023
IV
2g
Q8
Sp TAHBSO
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes